SE8206744D0 - Preparat for kontrollerad avgivning av substanser - Google Patents

Preparat for kontrollerad avgivning av substanser

Info

Publication number
SE8206744D0
SE8206744D0 SE8206744A SE8206744A SE8206744D0 SE 8206744 D0 SE8206744 D0 SE 8206744D0 SE 8206744 A SE8206744 A SE 8206744A SE 8206744 A SE8206744 A SE 8206744A SE 8206744 D0 SE8206744 D0 SE 8206744D0
Authority
SE
Sweden
Prior art keywords
substances
preparation
controlled release
mixture
controlled
Prior art date
Application number
SE8206744A
Other languages
English (en)
Swedish (sv)
Inventor
B Lindman
S Engstrom
Original Assignee
Fluidcarbon International Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20348752&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE8206744(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Publication of SE8206744D0 publication Critical patent/SE8206744D0/xx
Priority to SE8206744A priority Critical patent/SE8206744D0/xx
Application filed by Fluidcarbon International Ab filed Critical Fluidcarbon International Ab
Priority to AU23396/84A priority patent/AU2339684A/en
Priority to DE8383903841T priority patent/DE3376467D1/de
Priority to PCT/SE1983/000411 priority patent/WO1984002076A1/en
Priority to EP83903841A priority patent/EP0126751B2/de
Priority to JP84500018A priority patent/JPS60500256A/ja
Priority to AT83903841T priority patent/ATE33938T1/de
Priority to DK362284A priority patent/DK166752B1/da
Priority to NO843023A priority patent/NO173315C/no
Priority to FI842983A priority patent/FI83036C/fi
Priority to AU18193/88A priority patent/AU615453B2/en
Priority to US07/540,441 priority patent/US5151272A/en
Priority to US08/313,543 priority patent/US5753259A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases, cochleates; Sponge phases
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/829—Liposomes, e.g. encapsulation
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2984—Microcapsule with fluid core [includes liposome]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrrole Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SE8206744A 1982-11-26 1982-11-26 Preparat for kontrollerad avgivning av substanser SE8206744D0 (sv)

Priority Applications (13)

Application Number Priority Date Filing Date Title
SE8206744A SE8206744D0 (sv) 1982-11-26 1982-11-26 Preparat for kontrollerad avgivning av substanser
AU23396/84A AU2339684A (en) 1982-11-26 1983-11-25 Method of preparing controlled-release preparations for bio-
DE8383903841T DE3376467D1 (en) 1982-11-26 1983-11-25 Method of preparing controlled-release preparations for biologically active materials
PCT/SE1983/000411 WO1984002076A1 (en) 1982-11-26 1983-11-25 Method of preparing controlled-release preparations for biologically active materials and resulting compositions
EP83903841A EP0126751B2 (de) 1982-11-26 1983-11-25 Herstellungsverfahren von zusammensetzungen mit kontrolliertem verabreichen biologisch aktiver materialien
JP84500018A JPS60500256A (ja) 1982-11-26 1983-11-25 生物学的活性材料用の制御下開放配合物の調製方法及び得られる組成物
AT83903841T ATE33938T1 (de) 1982-11-26 1983-11-25 Herstellungsverfahren von zusammensetzungen mit kontrolliertem verabreichen biologisch aktiver materialien.
DK362284A DK166752B1 (da) 1982-11-26 1984-07-24 Fremgangsmaade til fremstilling af praeparater med reguleret frigoerelse af biologisk aktive materialer
NO843023A NO173315C (no) 1982-11-26 1984-07-25 Fremgangsm}te for fremstilling av flytende krystaller medstyrt frigivelse av et biologisk aktivt material
FI842983A FI83036C (fi) 1982-11-26 1984-07-26 Foerfarande foer framstaellning av en komposition, vilken avger reglerbart ett biologiskt aktivt aemne.
AU18193/88A AU615453B2 (en) 1982-11-26 1988-06-21 Method of preparing controlled-release preparations for biologically active materials and resulting compositions
US07/540,441 US5151272A (en) 1982-11-26 1990-06-18 Method of preparing controlled-release preparations for biologically active materials and resulting compositions
US08/313,543 US5753259A (en) 1982-11-26 1994-09-27 Method of preparing controlled-release preparations for biologically active materials and resulting compositions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8206744A SE8206744D0 (sv) 1982-11-26 1982-11-26 Preparat for kontrollerad avgivning av substanser

Publications (1)

Publication Number Publication Date
SE8206744D0 true SE8206744D0 (sv) 1982-11-26

Family

ID=20348752

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8206744A SE8206744D0 (sv) 1982-11-26 1982-11-26 Preparat for kontrollerad avgivning av substanser

Country Status (11)

Country Link
US (2) US5151272A (de)
EP (1) EP0126751B2 (de)
JP (1) JPS60500256A (de)
AT (1) ATE33938T1 (de)
AU (2) AU2339684A (de)
DE (1) DE3376467D1 (de)
DK (1) DK166752B1 (de)
FI (1) FI83036C (de)
NO (1) NO173315C (de)
SE (1) SE8206744D0 (de)
WO (1) WO1984002076A1 (de)

Families Citing this family (124)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8206744D0 (sv) * 1982-11-26 1982-11-26 Fluidcarbon International Ab Preparat for kontrollerad avgivning av substanser
IL79114A (en) * 1985-08-07 1990-09-17 Allergan Pharma Method and composition for making liposomes
US6759057B1 (en) 1986-06-12 2004-07-06 The Liposome Company, Inc. Methods and compositions using liposome-encapsulated non-steroidal anti-inflammatory drugs
ES2036593T3 (es) * 1986-06-12 1993-06-01 The Liposome Company, Inc. Composiciones que utilizan medicamentos antiinflamatorios no esteroidales encapsulados en liposomas.
US5371109A (en) * 1986-07-01 1994-12-06 Drilletten Ab Controlled release composition for a biologically active material dissolved or dispersed in an L2-phase
US5030452A (en) * 1989-01-12 1991-07-09 Pfizer Inc. Dispensing devices powered by lyotropic liquid crystals
GB8906234D0 (en) * 1989-03-17 1989-05-04 Albright & Wilson Agrochemical suspensions
US5196201A (en) * 1989-10-20 1993-03-23 Bioapatite Ab Implant material composition, preparation thereof as well as uses thereof and implant product obtainable therefrom
US5143934A (en) * 1990-11-21 1992-09-01 A/S Dumex (Dumex Ltd.) Method and composition for controlled delivery of biologically active agents
US5665379A (en) * 1990-09-28 1997-09-09 Pharmacia & Upjohn Aktiebolag Lipid particle forming matrix, preparation and use thereof
FR2681781A1 (fr) 1991-09-30 1993-04-02 Oreal Composition cosmetique anhydre de maquillage comprenant une phase grasse et procede de traitement cosmetique utilisant cette composition.
ES2133391T3 (es) * 1991-10-04 1999-09-16 Gs Dev Ab Particulas, metodo para preparar dichas particulas y usos de las mismas.
WO1993006921A1 (en) * 1991-10-04 1993-04-15 Gs Biochem Ab Particles, method of preparing said particles and uses thereof
CA2082561A1 (en) * 1991-11-12 1993-05-13 Francis J. Leng Antiperspirant materials and compositions
SE9200951D0 (sv) * 1992-03-27 1992-03-27 Kabi Pharmacia Ab Pharmaceutical composition containing a defined lipid system
US5981719A (en) 1993-03-09 1999-11-09 Epic Therapeutics, Inc. Macromolecular microparticles and methods of production and use
US6090925A (en) 1993-03-09 2000-07-18 Epic Therapeutics, Inc. Macromolecular microparticles and methods of production and use
WO1995005176A1 (en) * 1993-08-18 1995-02-23 Alcon Laboratories, Inc. Use of ergoline derivatives for the treatment of glaucoma
KR100220546B1 (ko) * 1994-02-04 1999-09-15 벵 헤르슬로프 호지성 담체 제제
HUT75459A (en) * 1994-02-04 1997-05-28 Scotia Lipidteknik Ab Carrier compositions comprising lipid-solvent bilayer
JP3117145B2 (ja) * 1994-02-04 2000-12-11 スコーツイア・リピツドテクニク・アクチエボラーグ 水中油エマルジョン
FR2720937B1 (fr) * 1994-06-08 1997-03-28 Oreal Composition cosmétique ou dermatologique sous forme de dispersion, aqueuse et stable, de particules de gel cubique à base de phytantriol et contenant un agent tensioactif à chaîne grasse en tant qu'agent dispersant et stabilisant.
SE518578C2 (sv) * 1994-06-15 2002-10-29 Gs Dev Ab Lipidbaserad komposition
SE518619C2 (sv) 1994-12-09 2002-10-29 Gs Dev Ab Komposition för reglerad frisättning innehållande monokaproin
FR2726762B1 (fr) * 1994-11-10 1997-01-17 Oreal Composition cosmetique ou dermatologique sous forme d'une dispersion d'une phase huileuse dans une phase aqueuse stabilisee a l'aide de particules de gel cubique et son procede d'obtention
FR2738565B1 (fr) * 1995-09-13 1997-11-28 Dior Christian Parfums Produits extraits d'une plante du genre commiphora, en particulier de la plante commiphora mukul, et extraits en contenant et leurs applications notamment en cosmetique
CO4910145A1 (es) 1996-10-01 2000-04-24 Smithkline Beecham Corp Uso
WO1998014189A1 (en) * 1996-10-01 1998-04-09 Smithkline Beecham Corporation Use of mupirocin for the manufacture of a medicament for the treatment of bacterial infections associated with colonisation of the nasopharynx by pathogenic organisms
JP4792149B2 (ja) 1997-09-09 2011-10-12 リオトロピック セラピュティックス アイエヌシー． 被覆粒子とその製造法及び使用法
US6638621B2 (en) * 2000-08-16 2003-10-28 Lyotropic Therapeutics, Inc. Coated particles, methods of making and using
EP0948902A1 (de) * 1998-03-13 1999-10-13 Societe Des Produits Nestle S.A. Nahrungsmittel enthaltend eine mesomorphe Phase aus Monoglyceride
US6761903B2 (en) 1999-06-30 2004-07-13 Lipocine, Inc. Clear oil-containing pharmaceutical compositions containing a therapeutic agent
US6458383B2 (en) 1999-08-17 2002-10-01 Lipocine, Inc. Pharmaceutical dosage form for oral administration of hydrophilic drugs, particularly low molecular weight heparin
WO2001010411A2 (de) 1999-08-06 2001-02-15 Max-Delbrück-Centrum für Molekulare Medizin Implantierbares wirkstoffdepot
WO2001025223A1 (en) 1999-10-06 2001-04-12 The Research Foundation Of State University Of New York Stabilization of taxane-containing dispersed systems
GB0001449D0 (en) * 2000-01-21 2000-03-08 Cortendo Ab Compositions
KR20010100194A (ko) * 2000-03-13 2001-11-14 박호군 여러 가지 물질의 가용화용 조성물과 제형 및 그들의제조방법
US6465002B1 (en) 2000-03-13 2002-10-15 Brown University Research Foundation Liquid crystalline polymers
WO2001068124A2 (en) 2000-03-15 2001-09-20 The Brigham And Women's Hospital, Inc. Suppression of vascular disorders by mucosal administration of heat shock protein peptides
US20020153508A1 (en) * 2000-06-29 2002-10-24 Lynch Matthew Lawrence Cubic liquid crystalline compositions and methods for their preparation
DE10057769A1 (de) * 2000-11-22 2002-05-23 Beiersdorf Ag Haarpflegeprodukte mit einem Gehalt an dispersen Flüssigkristallen, welche kubische Phasen darstellen
DE10057770A1 (de) * 2000-11-22 2002-05-23 Beiersdorf Ag Hautpflegeprodukte mit einem Gehalt an dispersen Flüssigkristallen, welche kubische Phasen darstellen ,
CA2428993C (en) * 2000-11-29 2011-05-31 Lyotropic Therapeutics, Inc. Solvent systems for pharmaceutical agents
US6936187B2 (en) * 2001-02-21 2005-08-30 Matthew Lawrence Lynch Functionalized cubic liquid crystalline phase materials and methods for their preparation and use
US6656385B2 (en) * 2001-02-21 2003-12-02 The Procter & Gamble Company Functionalized cubic liquid crystalline phase materials and methods for their preparation and use
DE10127406A1 (de) * 2001-06-06 2002-12-12 Xzillion Gmbh & Co Kg Verfahren zur elektrophoretischen Trennung von Proben
DE60221287T4 (de) * 2001-11-08 2009-06-25 Atrium Medical Corp. Intraluminale vorrichtung mit einer ein therapeutisches-mittel enthaltenden beschichtung
US20040022820A1 (en) * 2001-11-28 2004-02-05 David Anderson Reversed liquid crystalline phases with non-paraffin hydrophobes
CN1665480A (zh) * 2002-05-03 2005-09-07 儿童医院医疗中心 用于清洁皮肤及其他用途的模拟胎脂组合物
US20040018237A1 (en) 2002-05-31 2004-01-29 Perricone Nicholas V. Topical drug delivery using phosphatidylcholine
DE10251963A1 (de) * 2002-11-08 2004-05-19 Lts Lohmann Therapie-Systeme Ag Transmucosale pharmazeutische Darreichungsform
US20050119340A1 (en) * 2003-06-13 2005-06-02 David Anderson Treatment methods with low-dose, longer-acting formulations of local anesthetics and other agents
EP1667656A4 (de) * 2003-09-01 2011-12-28 Mayne Pharma Int Pty Ltd Zusammensetzungen und verfahren zur abgabe von biologisch wirksamen mitteln
US7713440B2 (en) * 2003-10-08 2010-05-11 Lyotropic Therapeutics, Inc. Stabilized uncoated particles of reversed liquid crystalline phase materials
KR20050081092A (ko) * 2004-02-12 2005-08-18 한국과학기술연구원 생체적합성 친수성 고분자를 포함하는 콜로이드계 조성물,제형 및 이들의 제조 방법
SE0401942D0 (sv) * 2004-07-28 2004-07-28 Lipopeptide Ab New antimicrobial peptide complexes
US9801913B2 (en) 2004-09-28 2017-10-31 Atrium Medical Corporation Barrier layer
US9012506B2 (en) 2004-09-28 2015-04-21 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
US9000040B2 (en) 2004-09-28 2015-04-07 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
US8367099B2 (en) 2004-09-28 2013-02-05 Atrium Medical Corporation Perforated fatty acid films
US9801982B2 (en) 2004-09-28 2017-10-31 Atrium Medical Corporation Implantable barrier device
WO2006036970A2 (en) * 2004-09-28 2006-04-06 Atrium Medical Corporation Method of thickening a coating using a drug
US8263102B2 (en) * 2004-09-28 2012-09-11 Atrium Medical Corporation Drug delivery coating for use with a stent
US8312836B2 (en) 2004-09-28 2012-11-20 Atrium Medical Corporation Method and apparatus for application of a fresh coating on a medical device
US20070059350A1 (en) * 2004-12-13 2007-03-15 Kennedy John P Agents for controlling biological fluids and methods of use thereof
US8535709B2 (en) * 2004-12-13 2013-09-17 Southeastern Medical Technologies, Llc Agents for controlling biological fluids and methods of use thereof
US20060127437A1 (en) * 2004-12-13 2006-06-15 Misty Anderson Kennedy Semisolid system and combination semisolid, multiparticulate system for sealing tissues and/or controlling biological fluids
WO2006072946A2 (en) 2005-01-04 2006-07-13 Yeda Research And Development Co. Ltd. At The Weizmann Institute Of Science Hsp60, hsp60 peptides and t cell vaccines for immunomodulation
US7125954B2 (en) * 2005-01-27 2006-10-24 General Electric Company Method for producing polyether polymers
EP1874334A4 (de) * 2005-04-15 2011-03-30 Vascular Biogenics Ltd Zusammensetzungen mit von beta 2-glykoprotein i stammenden peptiden zur prävention und/oder behandlung von gefässerkrankungen
US9278161B2 (en) 2005-09-28 2016-03-08 Atrium Medical Corporation Tissue-separating fatty acid adhesion barrier
US9427423B2 (en) 2009-03-10 2016-08-30 Atrium Medical Corporation Fatty-acid based particles
CA2626030A1 (en) 2005-10-15 2007-04-26 Atrium Medical Corporation Hydrophobic cross-linked gels for bioabsorbable drug carrier coatings
WO2008057328A2 (en) 2006-11-06 2008-05-15 Atrium Medical Corporation Tissue separating device with reinforced support for anchoring mechanisms
US9492596B2 (en) 2006-11-06 2016-11-15 Atrium Medical Corporation Barrier layer with underlying medical device and one or more reinforcing support structures
CZ299218B6 (cs) * 2006-11-07 2008-05-21 Zentiva, A. S. Kompozice depotních olanzapinových injekcních systému
CA2711114A1 (en) * 2008-01-02 2009-07-16 Kringle Pharma Inc. Topical compositions for the controlled delivery of proteins and peptides
US8603999B2 (en) 2008-12-05 2013-12-10 Commonwealth Scientific And Industrial Research Organisation Amphiphile prodrugs
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
US20110038910A1 (en) 2009-08-11 2011-02-17 Atrium Medical Corporation Anti-infective antimicrobial-containing biomaterials
EP2593141B1 (de) 2010-07-16 2018-07-04 Atrium Medical Corporation Zusammensetzung und verfahren zur veränderung der geschwindigkeit einer hydrolyse ausgehärteter materialien auf ölbasis
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
WO2012125214A1 (en) 2011-03-17 2012-09-20 Transdermal Biotechnology, Inc. Topical nitric oxide systems and methods of use thereof
JP6081480B2 (ja) 2011-12-05 2017-02-15 カムルス エービー 頑強な徐放性製剤
US9867880B2 (en) 2012-06-13 2018-01-16 Atrium Medical Corporation Cured oil-hydrogel biomaterial compositions for controlled drug delivery
US8871255B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Treatment of skin and soft tissue infection with nitric oxide
US8871258B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Treatment and prevention of learning and memory disorders
US8871262B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Compositions and methods for treatment of osteoporosis and other indications
US8871260B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Methods and compositions for muscular and neuromuscular diseases
US8871259B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Techniques and systems for treatment of neuropathic pain and other indications
US8871254B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Systems and methods for treatment of acne vulgaris and other conditions with a topical nitric oxide delivery system
US8871257B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Prevention and treatment of cardiovascular diseases using systems and methods for transdermal nitric oxide delivery
US8871261B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Cancer treatments and compositions for use thereof
US8871256B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Methods and systems for treatment of inflammatory diseases with nitric oxide
WO2014056939A1 (en) 2012-10-08 2014-04-17 Universität Zürich Lipidic biomaterials for encapsulation and triggered release
US9314417B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Treatment of skin, including aging skin, to improve appearance
US9241899B2 (en) 2013-03-13 2016-01-26 Transdermal Biotechnology, Inc. Topical systems and methods for treating sexual dysfunction
US9387159B2 (en) 2013-03-13 2016-07-12 Transdermal Biotechnology, Inc. Treatment of skin, including aging skin, to improve appearance
US9314422B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Peptide systems and methods for metabolic conditions
US9724419B2 (en) 2013-03-13 2017-08-08 Transdermal Biotechnology, Inc. Peptide systems and methods for metabolic conditions
US9849160B2 (en) 2013-03-13 2017-12-26 Transdermal Biotechnology, Inc. Methods and systems for treating or preventing cancer
US9314433B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Methods and systems for treating or preventing cancer
US9687520B2 (en) 2013-03-13 2017-06-27 Transdermal Biotechnology, Inc. Memory or learning improvement using peptide and other compositions
US9320706B2 (en) 2013-03-13 2016-04-26 Transdermal Biotechnology, Inc. Immune modulation using peptides and other compositions
US9339457B2 (en) 2013-03-13 2016-05-17 Transdermal Biotechnology, Inc. Cardiovascular disease treatment and prevention
US20140271731A1 (en) 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Cardiovascular disease treatment and prevention
US9295647B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Systems and methods for delivery of peptides
US9320758B2 (en) 2013-03-13 2016-04-26 Transdermal Biotechnology, Inc. Brain and neural treatments comprising peptides and other compositions
US9393265B2 (en) 2013-03-13 2016-07-19 Transdermal Biotechnology, Inc. Wound healing using topical systems and methods
US20140271938A1 (en) 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Systems and methods for delivery of peptides
US9750787B2 (en) 2013-03-13 2017-09-05 Transdermal Biotechnology, Inc. Memory or learning improvement using peptide and other compositions
US9295637B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Compositions and methods for affecting mood states
US9314423B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Hair treatment systems and methods using peptides and other compositions
US20140271937A1 (en) 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Brain and neural treatments comprising peptides and other compositions
US9393264B2 (en) 2013-03-13 2016-07-19 Transdermal Biotechnology, Inc. Immune modulation using peptides and other compositions
US9295636B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Wound healing using topical systems and methods
WO2016033556A1 (en) 2014-08-28 2016-03-03 Lipocine Inc. BIOAVAILABLE SOLID STATE (17-β)-HYDROXY-4-ANDROSTEN-3-ONE ESTERS
WO2016033549A2 (en) 2014-08-28 2016-03-03 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
US10722462B2 (en) 2014-12-10 2020-07-28 Council Of Scientific And Industrial Research Discontinuous reverse micellar composition in cubic FD3M phase for sustained release of therapeutic drugs
US20180147215A1 (en) 2016-11-28 2018-05-31 Lipocine Inc. Oral testosterone undecanoate therapy
WO2024068672A1 (en) * 2022-09-26 2024-04-04 Universität Bern Structured lipid compositions

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4073943A (en) * 1974-09-11 1978-02-14 Apoteksvarucentralen Vitrum Ab Method of enhancing the administration of pharmalogically active agents
US4115313A (en) * 1974-10-08 1978-09-19 Irving Lyon Bile acid emulsions
US4217344A (en) * 1976-06-23 1980-08-12 L'oreal Compositions containing aqueous dispersions of lipid spheres
US4086257A (en) * 1976-10-12 1978-04-25 Sears Barry D Phosphatidyl quaternary ammonium compounds
JPS5356315A (en) * 1976-11-01 1978-05-22 Eisai Co Ltd Emulsified solution of fat soluble drugs
JPS53107408A (en) * 1977-02-28 1978-09-19 Yamanouchi Pharmaceut Co Ltd Micellar preparation for rectal infusion
US4235871A (en) * 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
JPS54122719A (en) * 1978-03-16 1979-09-22 Sankyo Co Ltd Carcinostatic agent for oral administration
US4377567A (en) * 1978-10-02 1983-03-22 The Procter & Gamble Company Lipid membrane drug delivery
US4241046A (en) * 1978-11-30 1980-12-23 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
IT1129711B (it) * 1980-01-23 1986-06-11 Montedison Spa Formulazioni solide contenenti ferormoni
US4342826A (en) * 1980-02-04 1982-08-03 Collaborative Research, Inc. Immunoassay products and methods
JPS609726B2 (ja) * 1980-05-15 1985-03-12 株式会社 ミドリ十字 ステロイド製剤
JPS574913A (en) * 1980-06-11 1982-01-11 Green Cross Corp:The Urokinase preparation for oral administration
US4331654A (en) * 1980-06-13 1982-05-25 Eli Lilly And Company Magnetically-localizable, biodegradable lipid microspheres
JPS5775916A (en) * 1980-10-29 1982-05-12 Nippon Chemiphar Co Ltd Coenzyme q pharmaceutical and its preparation
JPS5793909A (en) * 1980-12-03 1982-06-11 Sankyo Co Ltd Carcinostatic pharmaceutical having directivity to specific internal organ and its preparation
JPS5716818A (en) * 1981-04-25 1982-01-28 Green Cross Corp:The Steroid fatty emulsion
SE8206744D0 (sv) * 1982-11-26 1982-11-26 Fluidcarbon International Ab Preparat for kontrollerad avgivning av substanser
US4789633A (en) * 1984-04-19 1988-12-06 University Of Tennessee Research Corporation Fused liposome and acid induced method for liposome fusion
US5143934A (en) * 1990-11-21 1992-09-01 A/S Dumex (Dumex Ltd.) Method and composition for controlled delivery of biologically active agents
US5262164A (en) * 1989-11-17 1993-11-16 The Procter & Gamble Company Sustained release compositions for treating periodontal disease

Also Published As

Publication number Publication date
US5151272A (en) 1992-09-29
EP0126751B1 (de) 1988-05-04
DE3376467D1 (en) 1988-06-09
FI842983A0 (fi) 1984-07-26
ATE33938T1 (de) 1988-05-15
EP0126751B2 (de) 1993-01-20
DK362284D0 (da) 1984-07-24
AU2339684A (en) 1984-06-18
NO843023L (no) 1984-07-25
AU1819388A (en) 1988-10-27
DK362284A (da) 1984-07-24
NO173315B (no) 1993-08-23
FI83036B (fi) 1991-02-15
DK166752B1 (da) 1993-07-12
NO173315C (no) 1993-12-01
JPS60500256A (ja) 1985-02-28
US5753259A (en) 1998-05-19
FI83036C (fi) 1991-05-27
EP0126751A1 (de) 1984-12-05
AU615453B2 (en) 1991-10-03
FI842983A (fi) 1984-07-26
WO1984002076A1 (en) 1984-06-07

Similar Documents

Publication Publication Date Title
SE8206744D0 (sv) Preparat for kontrollerad avgivning av substanser
FI964959A0 (fi) Diasyyliglyserolia, fosfolipidiä, polaarista nestettä ja biologisesti aktiivista materiaalia sisältävä lipidipohjainen koostumus
ES8400870A1 (es) Un procedimiento para la preparacion de un articulo moldeado solido que comporta una cantidad unitaria predeterminada de un producto quimico.
ZA847165B (en) Carbonylmethylene-heterocyclic compounds containing trihalogeno-methyl groups,process for their preparation,and light-sensitive mixture containing the compounds
DE69123075D1 (de) Ueberzogene Zusammensetzung sowie Verfahren zu ihrer Herstellung
EP0003833A3 (en) Antigen derivatives, process for their preparation, pharmaceutical compositions containing them, starting materials and their preparation
FR2535969B1 (fr) Compose ether de polyol, son procede de preparation et composition cosmetique le contenant
IT1171477B (it) Derivati del 4h-1,2,4-triazolo procedimento per la loro preparazione, loro impiego in quanto farmaci, composizioni che li contengono e prodotti intermedi ottenuti
ES485842A0 (es) Procedimiento para la obtencion de preparados de valepotria-tos en forma de microcapsulas.
JPS56131718A (en) Manhole cover
JPS52114013A (en) Trapping of active sbustance into liposome
JPS5241291A (en) Materials used for tissue culture
JPS521752A (en) Method and apparatus of continuously drying granular materials
JPS51125125A (en) Anchoring agent for laminated film
JPS52112652A (en) Improved asphalt urethane resin composition
DE3372765D1 (en) Carbamic-acid esters, process and starting material for their preparation, parasiticides containing these esters as active products, as well as the use of such esters and agents in combating parasites
JPS5221314A (en) Base material for ointments
JPS51119040A (en) Preparation of heat-resistant coating materials
JPS51140561A (en) Liquid phase epitaxial growing method
JPS5294960A (en) Friction material
JPS52117282A (en) Granulation apparatus
JPS5226381A (en) Liouid phase epitaxial growth method
JPS5534956A (en) Method of manufacturing transparent film for food packing
JPS5212173A (en) Novel method of preparing 0-amino- butyrophenone derivatives
DE2964911D1 (en) 4-phenyl-1,3-benzodiazepines, method for their preparation, pharmaceutical compositions containing them, and the compounds for use as medicaments